AC
CL icon

Avestar Capital’s Colgate-Palmolive CL Stock Holding History

Avestar Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$796K Buy
9,336
+747
+9% +$66.6K 0.05% 266
2025
Q4 		$679K Buy
8,589
+4,973
+138% +$390K 0.04% 279
2025
Q3 		$289K Sell
3,616
-4,221
-54% -$360K 0.02% 418
2025
Q2 		$712K Buy
7,837
+3,199
+69% +$292K 0.05% 271
2025
Q1 		$435K Sell
4,638
-504
-10% -$45.1K 0.04% 310
2024
Q4 		$467K Buy
5,142
+649
+14% +$61.9K 0.04% 302
2024
Q3 		$466K Buy
4,493
+394
+10% +$40.2K 0.05% 265
2024
Q2 		$398K Buy
4,099
+412
+11% +$38K 0.04% 284
2024
Q1 		$332K Buy
3,687
+906
+33% +$76.8K 0.03% 321
2023
Q4 		$222K Buy
+2,781
New +$209K 0.03% 343
2019
Q3 		– Sell
-197
Closed -$13K – 299
2019
Q2 		$13K Hold
197
– – 0.01% 456
2019
Q1 		$13K Hold
197
– – 0.01% 434
2018
Q4 		$10K Buy
197
+1
+0.5% +$63 0.01% 436
2018
Q3 		$11K Buy
196
+8
+4% +$533 0.01% 448
2018
Q2 		$10K Buy
188
+21
+13% +$1.37K 0.01% 460
2018
Q1 		$11K Buy
167
+21
+14% +$1.51K 0.01% 404
2017
Q4 		$10K Buy
+146
New +$10.7K 0.01% 439

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Avestar Capital's CL Position: Q1 2026 in Review

Avestar Capital increased its Colgate-Palmolive (CL) stake by 8.7% in Q1 2026, buying an estimated $66.6K and bringing the position to 9,336 shares worth $796K. The position accounts for 0.05% of the portfolio, ranked #266.

Avestar Capital first reported a position in CL in Q4 2017 and has held it in 17 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Avestar Capital held 9,336 shares of Colgate-Palmolive worth $796K as of Q1 2026.
  • Avestar Capital bought 747 Colgate-Palmolive shares in Q1 2026, an estimated $66.6K.
  • Colgate-Palmolive made up 0.05% of Avestar Capital's portfolio in Q1 2026, its #266 holding.
  • Avestar Capital first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 17 quarters since.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Avestar Capital's 13F filing for Q1 2026, filed 13 May 2026.